This policy statement should be used to guide use of noncommercial culture and DST methods for TB diagnosis in national TB control programmes. It is intended for use by national TB control programme managers and laboratory directors, in coordination with external laboratory consultants, donor agencies, technical advisors, laboratory technicians, laboratory equipment procurement officers, warehouse managers, other service providers, other relevant government officials and implementing partners involved in country-level TB laboratory strengthening. People responsible for programme planning, budgeting, resource mobilization and training for TB diagnostic services may also benefit from reading this document.
All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).
Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form/en/index.html).
World Health Organization, Geneva
Noncommercial Culture and Drug-Susceptibility Testing Methods for Screening Patients at Risk for Multidrug-Resistant Tuberculosis: Policy Statement. Geneva: World Health Organization; 2011. 5, Intended audience.